Cardio-oncology & otherCohort study
Economic burden of cardiovascular diseases in the European Union: a population-based cost study
- Population-based cost study
Aggregate country-specific resource use data from international sources (e.g. Eurostat), ESC Atlas programme and patient-level SHARE data; country-specific unit costs, per capita, adjusted for price differentials
Authors' conclusion
This study provides contemporary estimates of the wide-ranging impact of CVD on all aspects of the economy.
Study context
- Population
- 27 European Union (EU) countries, 202127 EU countries
- Outcome
- Economic burden of CVD
- Follow-up
- 2021
Main finding
As reported in the abstract
Annual cost of CVD to the EU
- Total annual cost
- €282 billion
- Health and long-term care
- €155 billion (55%)
- Health and long-term care, share of EU-health expenditure
- 11%
- Productivity losses
- 17% (€48 billion)
- Informal care
- €79 billion (28%)
- Cost per person
- €630
- Cost per person, lowest (Cyprus)
- €381
- Cost per person, highest (Germany)
- €903
Observational data: associations, not effects.
Further findings
Cardiovascular disease (CVD) costs by disease
- CHD
- 27% (€77 billion)
- Cerebrovascular diseases
- 27% (€76 billion)
Original publication
Economic burden of cardiovascular diseases in the European Union: a population-based cost study. Eur Heart J. Published 26 August 2023. doi:10.1093/eurheartj/ehad583
Summarised from the published abstract; every number is checked against it